Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 3

1.

Prediagnostic body fat and risk of death from amyotrophic lateral sclerosis: the EPIC cohort.

Gallo V, Wark PA, Jenab M, Pearce N, Brayne C, Vermeulen R, Andersen PM, Hallmans G, Kyrozis A, Vanacore N, Vahdaninia M, Grote V, Kaaks R, Mattiello A, Bueno-de-Mesquita HB, Peeters PH, Travis RC, Petersson J, Hansson O, Arriola L, Jimenez-Martin JM, Tjønneland A, Halkjær J, Agnoli C, Sacerdote C, Bonet C, Trichopoulou A, Gavrila D, Overvad K, Weiderpass E, Palli D, Quirós JR, Tumino R, Khaw KT, Wareham N, Barricante-Gurrea A, Fedirko V, Ferrari P, Clavel-Chapelon F, Boutron-Ruault MC, Boeing H, Vigl M, Middleton L, Riboli E, Vineis P.

Neurology. 2013 Feb 26;80(9):829-38. doi: 10.1212/WNL.0b013e3182840689. Epub 2013 Feb 6.

PMID:
23390184
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

[Clinical course and epidemiological analysis of amyotrophic lateral sclerosis in Szczecin in 1986-1995].

Potemkowski A, Honczarenko K, Fabian A.

Neurol Neurochir Pol. 1999 Jan-Feb;33(1):71-8. Review. Polish.

PMID:
10399726
[PubMed - indexed for MEDLINE]
3.

Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).

Miller RG, Mitchell JD, Lyon M, Moore DH.

Amyotroph Lateral Scler Other Motor Neuron Disord. 2003 Sep;4(3):191-206. Review.

PMID:
13129806
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk